Indications and uses
Nystatin Cream is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida (Monilia) albicans and other Candida species.
Nystatin Cream is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida (Monilia) albicans and other Candida species.
Nystatin Cream should be applied liberally to affected areas twice daily or as indicated until healing is complete. Nystatin Cream is usually preferred to Nystatin Ointment in candidiasis involving intertriginous areas; very moist lesions, however, are best treated with Nystatin Topical Powder.
Rx only
Nystatin Cream is for dermatologic use.
Nystatin is a polyene antimycotic obtained from Streptomyces noursei. It is a yellow to light tan powder with a cereal-like odor, very soluble in water, and slightly to sparingly soluble in alcohol. Structural formula:

Nystatin Cream contains the antifungal antibiotic nystatin at a concentration of 100,000 USP Nystatin Units per gram in an aqueous, perfumed cream base containing purified water, propylene glycol, methylparaben, propylparaben, white petrolatum, glyceryl monostearate, polyethylene glycol 400 monostearate, ceteareth-15, medical antifoam AF emulsion, aluminum hydroxide gel, titanium dioxide, sorbitol solution, and, if necessary, sodium hydroxide for pH adjustment.
Nystatin is an antifungal antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi. It probably acts by binding to sterols in the cell membrane of the fungus with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin is the first well tolerated antifungal antibiotic of dependable efficacy for the treatment of cutaneous, oral and intestinal infections caused by Candida (Monilia) albicans and other Candida species. It exhibits no appreciable activity against bacteria.
Nystatin provides specific therapy for all localized forms of candidiasis. Symptomatic relief is rapid, often occurring within 24 to 72 hours after the initiation of treatment. Cure is effected both clinically and mycologically in most cases of localized candidiasis.
Nystatin Cream is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida (Monilia) albicans and other Candida species.
Nystatin Cream is contraindicated in patients with a history of hypersensitivity to any of its components.
Should a reaction of hypersensitivity occur the drug should be immediately withdrawn and appropriate measures taken.
Nystatin Cream is not for ophthalmic use.
Nystatin is virtually nontoxic and nonsensitizing and is well tolerated by all age groups including debilitated infants, even on prolonged administration. If irritation on topical application should occur, discontinue medication.
Nystatin Cream should be applied liberally to affected areas twice daily or as indicated until healing is complete.
Nystatin Cream is usually preferred to Nystatin Ointment in candidiasis involving intertriginous areas; very moist lesions, however, are best treated with Nystatin Topical Powder.
Nystatin Cream is a smooth yellow cream with a characteristic perfume odor.
Nystatin Cream is supplied in 15g (NDC 21695-761-15) and 30g (NDC 21695-761-30) tubes providing 100,000 USP Nystatin Units per gram.
Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature].
Mfd. by: Taro Pharmaceuticals Inc.
Brampton, Ontario, Canada L6T 1C1
Dist. by: Taro Pharmaceuticals U.S.A., Inc.
Hawthorne, NY 10532
Repackaged by:
Rebel Distributors Corp
Thousand Oaks, CA 91320
| Class | Version | Type | Effective |
|---|---|---|---|
| NYSTATIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e29fe634-dc25-094c-c77f-5d09c3eceb3e | Product name | 5 | 20260107 |
| e57b6340-9387-3f9a-7307-511c81791375 | Product name | 3 | 20221214 |
| 544f8e8d-6389-eeeb-9586-aa447c08dcc7 | Product name | 5 | 20210614 |
| 1629e00f-54fb-4a43-8306-b58442b23902 | Product name | 9 | 20200430 |
| 854ec07b-1cd7-a5db-235a-7aa24d3cf97a | Product name | 3 | 20180628 |
| 19b9f4c1-15e9-edcc-4c16-f01ecfb5c549 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 21695-761-15 | 2019-09-24 | C162847 | 48780-1 | 934fe258-487e-48b1-e053-8cdaa90a720a | Nystatin Cream USP, 100,000 units per gram |
| 21695-761-30 | 2019-09-24 | C162847 | 48780-1 | 934fe258-487e-48b1-e053-8cdaa90a720a | Nystatin Cream USP, 100,000 units per gram |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21695-761-15 | Nystatin | 15 g in 1 TUBE | CREAM | 15 | 1 | |
| 21695-761-15 | Nystatin | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 21695-761-30 | Nystatin | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 21695-761-30 | Nystatin | 30 g in 1 TUBE | CREAM | 30 | 1 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 21695-761-15 | GM - Gram | 21695-761 | b5aaac98-43a4-4919-9a1e-74408bbaa008 | 1 | 2012-07-24 |
| 21695-761-30 | GM - Gram | 21695-761 | 3246afc3-3809-4ac8-b4ed-6770e5e0b180 | 1 | 2012-07-24 |
| 51672-1289-1 | GM - Gram | 51672-1289 | 38067616-cd05-468d-a844-b2ec0513e43f | 1 | 2012-07-24 |
| 51672-1289-2 | GM - Gram | 51672-1289 | 4f7b2183-b586-49ab-9a71-4e40d5479cb9 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Nystatin | ACTIVE INGREDIENT | BDF1O1C72E | 1 | |
| Nystatin | ACTIVE MOIETY | BDF1O1C72E | 1 | |
| ALGELDRATE | INACTIVE INGREDIENT | 03J11K103C | 1 | |
| CETEARETH-12 | INACTIVE INGREDIENT | 7V4MR24V5P | 1 | |
| glyceryl monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | 1 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 1 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | 1 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 21695-761 | 21695-761-15, 21695-761-30 |
| 51672-1289 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Nystatin | BDF1O1C72E | ACTIB |
| water | 059QF0KO0R | IACT |
| propylene glycol | 6DC9Q167V3 | IACT |
| methylparaben | A2I8C7HI9T | IACT |
| propylparaben | Z8IX2SC1OH | IACT |
| PETROLATUM | 4T6H12BN9U | IACT |
| glyceryl monostearate | 230OU9XXE4 | IACT |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | IACT |
| CETEARETH-12 | 7V4MR24V5P | IACT |
| ALGELDRATE | 03J11K103C | IACT |
| titanium dioxide | 15FIX9V2JP | IACT |
| SORBITOL | 506T60A25R | IACT |
| sodium hydroxide | 55X04QC32I | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CREAM / TOPICAL | 836 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| ALGELDRATE | ALGELDRATE | 03J11K103C | CREAM / TOPICAL | 5 %w/w | ||
| CETEARETH-12 | CETEARETH-12 | 7V4MR24V5P | CREAM / TOPICAL | 5 %w/w | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | CREAM / TOPICAL | 6 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CREAM / TOPICAL | 80 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / TOPICAL | 76000 mg | ||
| sodium hydroxide | SODIUM HYDROXIDE | 55X04QC32I | CREAM / TOPICAL | 69 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | CREAM / TOPICAL | 3000 mg | ||
| POLYETHYLENE GLYCOL 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | CREAM / TOPICAL | 10 %w/w | ||
| SORBITOL | SORBITOL | 506T60A25R | CREAM / TOPICAL | 36.8 %w/w |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A064022-001 | NYSTATIN | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 |
| Application-product | TE code |
|---|---|
| A064022-001 | AT |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | f41ea6bd6efb… |
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A064022-001 | AT | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A064022-001 | AT | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A064022-001 | AT | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A064022-001 | AT | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A064022-001 | AT | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A064022-001 | AT | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A064022-001 | AT | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A064022-001 | AT | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A064022-001 | AT | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A064022-001 | AT | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A064022-001 | AT | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A064022-001 | AT | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A064022-001 | AT | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A064022-001 | AT | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A064022-001 | AT | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A064022-001 | AT | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A064022-001 | AT | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A064022-001 | AT | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A064022-001 | AT | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A064022-001 | AT | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A064022-001 | AT | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A064022-001 | AT | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A064022-001 | AT | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A064022-001 | AT | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A064022-001 | AT | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A064022-001 | AT | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A064022-001 | AT | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A064022-001 | AT | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A064022-001 | AT | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A064022-001 | AT | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A064022-001 | AT | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A064022-001 | AT | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A064022-001 | AT | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A064022-001 | AT | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A064022-001 | AT | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A064022-001 | AT | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A064022-001 | AT | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A064022-001 | AT | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A064022-001 | AT | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A064022-001 | AT | 1 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nystatin | NYSTATIN | Sun Pharmaceutical Industries, Inc. | 4d845b3f-ca26-4c47-b424-b6d783cc10e5 | 2025-07-03 | Adverse reactions | 51672-1289 |
| fb98a6b8-da0c-40f4-9e53-487b541865b5 | fb98a6b8-da0c-40f4-9e53-487b541865b5 | 2010-10-08 | Adverse reactions | fb98a6b8-da0c-40f4-9e53-487b541865b5 fb98a6b8-da0c-40f4-9e53-487b541865b5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.